Navigation Links
IEC Centra CL3 Ventilated Centrifuge, 220-240V / 50/60 Hz from Thermo Scientific

ProductsIEC Centra CL3 Ventilated Centrifuge, 220-240V / 50/60 Hz from Thermo Scientific
Company Thermo Scientific
Item IEC Centra CL3 Ventilated Centrifuge, 220-240V / 50/60 Hz
Price 
Description The IEC Centra CL3 series is designed to enhance your productivity in typical research and clinical applications at a reasonable cost. A broad accessory package includes quick connect rotors and various biocontainment options. An advanced yet intuitive interface allows you to control and view centrifuge parameters.
Info Thermo ScientificThermo Scientific
450 Fortune Blvd.
Milford, MA 01757
Customer Service: North America: 1-877-THERMO-U
Fax Number: 508-520-2229
Web Site: http://www.thermo.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Thermo Scientific IEC Centra-CL5R from Thermo Scientific
2. Thermo Scientific IEC Centra-CL3 from Thermo Scientific
3. Wellmix (220-240V) from Thermo Scientific
4. Recorder, 6", 7 Day, 1 Pen, 0 to 100C, Free Standing, 115V, 50/60 Hz, for 4520, Customer Installed from Thermo Scientific
5. 80C Tabletop Incubator Shaker, 90-125V, 50/60 Hz or 180-250V, 50/60 Hz from Thermo Scientific
6. Tabletop Orbital Shaker, 90-126V, 50/60 Hz or 180-253V, 50/60 Hz from Thermo Scientific
7. Console Incubator Shaker, 108-125V, 50/60 Hz from Thermo Scientific
8. HEPA Filtered Single Chamber Water Jacketed Incubator, CO2/O2 IR, 115V, 50/60 Hz from Thermo Scientific
9. Thermo Sequenase Dye Primer Manual Cycle Sequencing Kit from USB Corp.
10. Finnigan Pocket Surveyor from Thermo Scientific
11. DSQ II Single Quadrupole GC/MS from Thermo Scientific
5-bromouridine 5'-triphosphate (BrUTP) *10 mM in TE buffer* from Molecular Probes (Invitrogen)
ER-beta Fluorescence polarization Assay Kit from Invitrogen
GIBCO MEM Non-Essential Amino Acids Solution 10 mM (100X), liquid from Invitrogen
...rains are K-12 derivatives that have mutations in ...one reductase (gor) genes, which greatly enhances ... have shown that expression in Origami(DE3) yielde... even though overall expression levels were simila...
Biology Products:
(Date:12/3/2009)The extinction of plant and animal species can be likened to emptying a museum of its collection, or dumping a cabinet full of potential medicines into the trash, or replacing every local cuisine with
(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re
(Date:12/3/2009)The UK leads the world when it comes to investment in energy efficient technologies research, but Engineering and Physical Sciences Research Council (EPSRC) Chief Executive Dave Delpy believes that mo
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Research is vital to a cleaner, greener, low carbon future 2By 2018 GlaxoSmithKlines Votrient Will Garner Sales of 24640 Million and Will Overtake Pfizers Sutent as the Renal Cell Carcinoma Market Leader 57010 1By 2018 GlaxoSmithKlines Votrient Will Garner Sales of 24640 Million and Will Overtake Pfizers Sutent as the Renal Cell Carcinoma Market Leader 57010 2Alexza Announces Preliminary Results from its AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2b Trial in Patients with Migraine Headache 4993 1Alexza Announces Preliminary Results from its AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2b Trial in Patients with Migraine Headache 4993 2Alexza Announces Preliminary Results from its AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2b Trial in Patients with Migraine Headache 4993 3Alexza Announces Preliminary Results from its AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2b Trial in Patients with Migraine Headache 4993 4Alexza Announces Preliminary Results from its AZ 104 28Staccato 28R 29 Loxapine 29 Phase 2b Trial in Patients with Migraine Headache 4993 5Heart Failure Society of America 13th Annual Scientific Meeting to Focus on a Bench To Bedside Approach 4989 1Heart Failure Society of America 13th Annual Scientific Meeting to Focus on a Bench To Bedside Approach 4989 2Heart Failure Society of America 13th Annual Scientific Meeting to Focus on a Bench To Bedside Approach 4989 3
...e fast disappearing from restaurant menus as stock... While the reasons for the eel decline remain as m...y a NOAA scientist and colleagues in Japan and the...nditions may be a primary factor in declining repr...ects of spawning and early life history of this sp...
...t of champions? That would be a soy protein-packed...ements for three different FDA health claims and l...at again until lunch. , University of Illinois sc...st such a cereal, one thats passed the taste test ...asons to eat soy--and even more reasons to consume...
...pleased to announce the launch of the Internationa...llows on the heels of the Panda Genome workshop he...Hongmei Zhu, a scientist from BGI-Shenzhen, stated...sequencing and assembling of the draft sequence wi...ved animal all over the world and is considered a ...
Other Biology News:Changes in ocean conditions in Sargasso Sea potential cause for decline in eel fishery 2Changes in ocean conditions in Sargasso Sea potential cause for decline in eel fishery 3U of I researcher develops power-packed soy breakfast cereal 2Giant panda genome to be sequenced 2Giant panda genome to be sequenced 3
(Date:12/4/2009)IRVINE, Calif., Dec. 4 BlueFire Ethanol Fuels, Inc. (OTC Bulletin Board: BFRE), a company focused on changing the world,s transportation fuel paradigm through the production of ethanol from non-food
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
Breaking Biology Technology:BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2